Login to Your Account

Gut-route shell out: Rani raises $50M-plus for oral forms of injectable drugs

By Randy Osborne
Staff Writer

Wednesday, February 24, 2016

Impressively partnered Rani Therapeutics Inc.'s latest round of "more than $50 million" brings to greater than $70 million the amount of cash raised thus far by the firm, which "could be in the clinic in the second half of next year with a molecule that we might develop on our own," CEO Mir Imran told BioWorld Today.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription